Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.82 HKD | +2.51% | +14.06% | -20.08% |
Apr. 22 | Cansino Bio Gets Nod for China Clinical Trials of Haemophilus Influenzae Vaccine | MT |
Apr. 22 | Cansino Biologics Pneumococcal Vaccine's Phase I Trial Offers Positive Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.08% | 1.07B | |
-4.66% | 87.53B | |
+2.63% | 40.42B | |
-20.13% | 29.48B | |
+57.86% | 25.43B | |
-17.89% | 11.49B | |
-44.02% | 11.3B | |
-9.14% | 11.1B | |
+5.24% | 8.75B | |
-8.42% | 7.99B |
- Stock Market
- Equities
- 6185 Stock
- News CanSino Biologics Inc.
- UBS Adjusts CanSino Biologics' Price Target to HK$88 From HK$200, Keeps at Buy